Thermo Fisher Scientific Inc.

NYSE:TMO Stok Raporu

Piyasa değeri: US$214.5b

Thermo Fisher Scientific Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 4/6

Thermo Fisher Scientific yıllık ortalama 5.9% oranında kazançlarını artırırken, Life Sciences sektöründe kazançlar growing at 12.7% annual. Gelirler growing yılda ortalama 10.9% oranında artmaktadır. Thermo Fisher Scientific'in özkaynak karlılığı 12.5% ve net marjı 14.5%'dir.

Anahtar bilgiler

5.9%

Kazanç büyüme oranı

6.7%

EPS büyüme oranı

Life Sciences Sektör Büyümesi21.5%
Gelir büyüme oranı10.9%
Özkaynak getirisi12.5%
Net Marj14.5%
Son Kazanç Güncellemesi28 Sep 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Thermo Fisher Scientific Q3: Expecting Market Recovery In FY25; Upgrade To 'Buy'

Oct 23

Thermo Fisher Scientific: Fantastic Company, Rich Valuation

Oct 04

These 4 Measures Indicate That Thermo Fisher Scientific (NYSE:TMO) Is Using Debt Reasonably Well

Sep 21
These 4 Measures Indicate That Thermo Fisher Scientific (NYSE:TMO) Is Using Debt Reasonably Well

Thermo Fisher Scientific Inc.'s (NYSE:TMO) Price Is Out Of Tune With Earnings

Aug 16
Thermo Fisher Scientific Inc.'s (NYSE:TMO) Price Is Out Of Tune With Earnings

Thermo Fisher Scientific: Microscopic Signs Of Growth Emerging

Jul 25

A Look At The Fair Value Of Thermo Fisher Scientific Inc. (NYSE:TMO)

Jul 11
A Look At The Fair Value Of Thermo Fisher Scientific Inc. (NYSE:TMO)

Is Thermo Fisher Scientific (NYSE:TMO) A Risky Investment?

Jun 18
Is Thermo Fisher Scientific (NYSE:TMO) A Risky Investment?

Low Yield, High Growth: Unveiling The Power Of Thermo Fisher's Dividends

Jun 07

Thermo Fisher: Renewed Growth Yet To Materialize, But Already Priced In (Rating Downgrade)

Apr 30

Thermo Fisher Scientific Inc. (NYSE:TMO) Just Released Its First-Quarter Earnings: Here's What Analysts Think

Apr 27
Thermo Fisher Scientific Inc. (NYSE:TMO) Just Released Its First-Quarter Earnings: Here's What Analysts Think

Why Thermo Fisher Scientific Inc. (NYSE:TMO) Could Be Worth Watching

Apr 24
Why Thermo Fisher Scientific Inc. (NYSE:TMO) Could Be Worth Watching

Thermo Fisher Scientific: Too Hot To Handle

Apr 15

Investors Still Waiting For A Pull Back In Thermo Fisher Scientific Inc. (NYSE:TMO)

Apr 02
Investors Still Waiting For A Pull Back In Thermo Fisher Scientific Inc. (NYSE:TMO)

We Think Thermo Fisher Scientific (NYSE:TMO) Can Stay On Top Of Its Debt

Mar 12
We Think Thermo Fisher Scientific (NYSE:TMO) Can Stay On Top Of Its Debt

Thermo Fisher's Bright Future Makes It A Great Buy On Weakness

Feb 06

Here's What Analysts Are Forecasting For Thermo Fisher Scientific Inc. (NYSE:TMO) After Its Yearly Results

Feb 02
Here's What Analysts Are Forecasting For Thermo Fisher Scientific Inc. (NYSE:TMO) After Its Yearly Results

Thermo Fisher: Blue Chip Stock Melded With Growth Characteristics

Jan 16

Thermo Fisher: Downturn In Pharma And Biotech And Weak China Growth; Initiate With 'Hold'

Jan 06

Is Now An Opportune Moment To Examine Thermo Fisher Scientific Inc. (NYSE:TMO)?

Dec 29
Is Now An Opportune Moment To Examine Thermo Fisher Scientific Inc. (NYSE:TMO)?

Does Thermo Fisher Scientific (NYSE:TMO) Have A Healthy Balance Sheet?

Dec 11
Does Thermo Fisher Scientific (NYSE:TMO) Have A Healthy Balance Sheet?

Thermo Fisher Scientific: I Am Still Waiting For An Attractive Buying Opportunity.

Dec 02

Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Could Be 25% Below Their Intrinsic Value Estimate

Nov 07
Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Could Be 25% Below Their Intrinsic Value Estimate

Gelir ve Gider Dağılımı

Thermo Fisher Scientific nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

NYSE:TMO Gelir, gider ve kazançlar (USD Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
28 Sep 2442,3706,1358,5121,343
29 Jun 2442,3466,2208,4691,316
30 Mar 2442,4926,0348,4341,322
31 Dec 2342,8575,9958,3811,337
30 Sep 2343,4215,9418,4641,401
01 Jul 2343,5245,7218,6531,433
01 Apr 2343,8076,0248,7811,453
31 Dec 2244,9156,9508,9401,471
01 Oct 2244,1677,0328,8541,472
02 Jul 2242,8207,4398,6111,472
02 Apr 2241,1237,6038,3171,450
31 Dec 2139,2117,7257,8571,406
02 Oct 2139,0598,5657,8431,390
03 Jul 2138,2508,5967,4621,335
03 Apr 2135,8947,9247,1991,256
31 Dec 2032,2186,3756,9401,181
26 Sep 2028,4974,8796,3601,067
27 Jun 2026,2483,7066,2921,018
28 Mar 2025,6473,6696,1141,000
31 Dec 1925,5423,6966,1391,003
28 Sep 1925,2203,5926,060992
29 Jun 1924,8683,5416,025985
30 Mar 1924,6303,1746,033981
31 Dec 1824,3582,9386,022967
29 Sep 1823,8982,5706,022949
30 Jun 1823,0942,3955,888926
31 Mar 1822,0062,2565,632906
31 Dec 1720,9182,2285,428887
30 Sep 1719,8242,3305,214867
01 Jul 1719,1992,2705,064833
01 Apr 1718,7442,1744,999794
31 Dec 1618,2742,0254,883754
01 Oct 1617,9731,9994,814723
02 Jul 1617,6062,0034,711711
02 Apr 1617,3411,9984,639703
31 Dec 1516,9651,9804,566692
26 Sep 1516,8061,9784,633695
27 Jun 1516,8541,9714,732698
28 Mar 1516,9051,7384,823707
31 Dec 1416,8901,8964,788691
27 Sep 1415,8641,6354,415613
28 Jun 1414,8841,4824,031534
29 Mar 1413,8021,4813,638447
31 Dec 1313,0901,2793,373396

Kaliteli Kazançlar: TMO yüksek kaliteli kazançlar sağlıyor.

Büyüyen Kar Marjı: TMO 'nin mevcut net kar marjları (14.5%) geçen yılın (13.7%) sinden daha yüksektir.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: TMO şirketinin kazancı son 5 yılda yılda 5.9% oranında arttı.

Büyüme Hızlandırma: TMO 'un son bir yıldaki kazanç büyümesi ( 3.3% ) 5 yıllık ortalamasının ( 5.9% /yıl) altındadır.

Kazançlar vs. Sektör: TMO geçen yılki kazanç büyümesi ( 3.3% ) Life Sciences sektörünün -4.7% değerini aştı.


Özkaynak Getirisi

Yüksek ROE: TMO 'nin Özsermaye Getirisi ( 12.5% ) düşük olarak değerlendiriliyor.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin